Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.00 | N/A |
| PEG Ratio (TTM) | -0.35 | N/A |
| P/S Ratio (TTM) | 0.85 | N/A |
| P/B Ratio (TTM) | 0.97 | N/A |
| P/FCF Ratio (TTM) | 9.92 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.94 | N/A |
| Price to 5YR AVG FCF Ratio | 9.20 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.09% | N/A |
| ROE (TTM) | 7.59% | N/A |
| Net Profit Margin (TTM) | 6.57% | N/A |
| ROIC 5YR AVG | 8.80% | N/A |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.83% | 5.21% | 5.76% |
| Revenue | 0.29% | 6.27% | 7.03% |
| Net Income | 19.04% | 5.52% | 6.34% |
| Cash Flow | 156.06% | 3.36% | 10.21% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.20 | N/A |
| Quick Ratio (TTM) | 0.72 | N/A |
| D/E Ratio (TTM) | 0.80 | N/A |
| Interest Coverage (TTM) | 2.58 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.40 | N/A |
| LTL to 5YR AVG FCF | 7.21 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.42% | N/A |